In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Beam Therapeutics Inc (NASDAQ: BEAM) was $22.78 for the day, down -1.51% from the previous closing price of $23.13. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 0.92 million shares were traded. BEAM stock price reached its highest trading level at $23.71 during the session, while it also had its lowest trading level at $22.66.
Ratios:
Our analysis of BEAM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.89 and its Current Ratio is at 5.89. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Upgraded its rating to Overweight and sets its target price to $40 from $38 previously.
On December 15, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $35.
Jefferies Downgraded its Buy to Hold on December 08, 2023, whereas the target price for the stock was revised from $75 to $30.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 02 ’24 when Simon Amy sold 16,530 shares for $30.54 per share. The transaction valued at 504,851 led to the insider holds 70,060 shares of the business.
Evans John M. sold 18,102 shares of BEAM for $581,617 on Apr 01 ’24. The CEO now owns 1,058,343 shares after completing the transaction at $32.13 per share. On Apr 01 ’24, another insider, Simon Amy, who serves as the Chief Medical Officer of the company, sold 7,157 shares for $32.13 each. As a result, the insider received 229,954 and left with 86,590 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 1903833984 and an Enterprise Value of 776779200. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.92 while its Price-to-Book (P/B) ratio in mrq is 1.89. Its current Enterprise Value per Revenue stands at 2.057 whereas that against EBITDA is -4.964.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $16.95. The 50-Day Moving Average of the stock is -26.51%, while the 200-Day Moving Average is calculated to be -15.86%.
Shares Statistics:
BEAM traded an average of 1.51M shares per day over the past three months and 1411810 shares per day over the past ten days. A total of 81.63M shares are outstanding, with a floating share count of 67.86M. Insiders hold about 16.89% of the company’s shares, while institutions hold 75.48% stake in the company. Shares short for BEAM as of 1713139200 were 13173332 with a Short Ratio of 8.71, compared to 1710460800 on 14320311. Therefore, it implies a Short% of Shares Outstanding of 13173332 and a Short% of Float of 20.969999.
